Navigation Links
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Date:5/15/2008

="http://www.onyx-pharm.com" target="_new">http://www.onyx-pharm.com.

Forward-Looking Statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the timing, progress and results of the clinical development, safety, regulatory processes, and commercialization efforts of Nexavar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals, Inc.

(1) Ferlay J, et al., GLOBOCAN 2002. Cancer Incidence, Mortality and
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
2. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
3. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
4. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
5. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
6. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
7. Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
8. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
9. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
10. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
11. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , DURHAM, N.C., Dec. 4 /PRNewswire-FirstCal...oard: OXBT) today announced that the first patient...se escalation, clinical trial in Switzerland for u...ry (TBI). Oxycyte is the Company,s perfluorocarbon...al is of invaluable importance in improving the ou...
(Date:12/4/2009)..., , ANNAPOLIS, Md., Dec. 4 /PRNewswire-Firs...biodefense company developing medical countermeasu...nced today the presentation of new data from the C...lyophilized recombinant Protective Antigen (rPA) b...tent after 16 months at various temperatures up to...
(Date:12/4/2009)..., , Opposes use of imported drugs often sto... Dec. 4 Today, the seni...efeat the Dorgan Importation plan encompassed in S..."Senator Dorgan,s importation amendment is poised ...g system to be breached, and our health to be enda...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 1Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 3Thomson Reuters Joins the InChI Trust 13612 1Thomson Reuters Joins the InChI Trust 13612 27 Easy Tips for Healthy Aging 54745 17 Easy Tips for Healthy Aging 54745 2
...et, Inc. (Nasdaq:,MITI), a biopharmaceutical compa...e treatment of cancer, inflammation and autoimmune...1) showing cytotoxic activity of,anti-EpCAM antibo... colon,cancer cells on November 1, 2008 at the 23r...Biological Therapy of Cancer (iSBTc) , taking,plac...
...ionovo, Inc.,(Nasdaq: BNVI ) announced today that...BZL101, will advance to Phase 2 clinical testing a... clinical trial., The Phase 1B clinical trial was...of BZL101 and to determine the safety and feasibil...ment. A total of 27 women with,metastatic breast c...
Other Medicine Technology:Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 2Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 3Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 4Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 5Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4
(Date:12/5/2009)...mpaign is a collaborative effort by the National A...PM), Midwives Alliance of North America (MANA), Ci...or Traditional Childbearing (ICTC), North American...ucation Accreditation Council (MEAC). To celebrat...ure federal recognition of CPMs language beneficia...
(Date:12/4/2009)...RNewswire/ -- Medithrive, Inc. has won the Patient...SF Bay Area by popular vote conducted by the onlin...months in operation, the SF Bay community has sele...essing medicinal marijuana. ,, The rapid rise...: a dispensary which caters to the consumer, provi...
(Date:12/4/2009)... Mich., Dec. 4 The Editorial Advis...sting Magazine today announced Allergan, Inc. (..." and C.R. Bard, Inc. (NYSE: BCR ) as its Febr...mational and educational use. ,, "The committee...volving its flagship drug Botox and other products...
(Date:12/4/2009)...dy shows that muscle cells grown in the lab can re...rly. The work, performed in dogs and rats, might u... as gastric reflux and fecal incontinence. , Thi...which are the bands of muscle that separate the ma... these areas can cause gastrointestinal esophageal...
(Date:12/4/2009)...ism is a phenomenon that was started by people tha...e of dental work in the US, Canada, and other coun...e, people have found that Mexican Dental Vacation ... , (PRWEB) December 4, 20...s, Mexican Dental Vacation is seeing their best ye...
Breaking Medicine News(10 mins):Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...linical trials of new drugs developed and would ma...argest potential of patients and diseases. Pharmac...l pharmaceutical companies would invest more than ...al Research and Department of Biotechnology have i...
...Affairs has approved to extend by five years the R...it over five million people.// The extension of...d involve an expenditure of Rs.11.56 billion ($255...t would be the treatment of 5.32 million TB patien...
...d people now a days need to be aware of the variou...xclusive information about //cosmetic surgery and ... The Department of Health says this website will ...ly many people opt for it. Hence there is a need t...
... intellect, according to McMaster University’s res...tudy which also said that there were differences b...shed in the journal Brain also said, said that in ...r right-handers only, indicating that brain asymme...
...s condition are more likely to smoke, and smoking ...asis results in inflammation and scaling of the sk...ack, elbows, knees, palms, face, and the soles of ...ology. Data from as many as 818 psoriasis p...
...at women with Alzheimer’s disease have low levels ...than women with a sound mental health. // The rese...s at the University of Chicago. Previous stu...a common characteristic of the disease. An...
Other Medicine News:Health News:Details of Cosmetic Surgery in a Special Website. 2Health News:Lack Of Estrogen In Brain Tissue Of Women Can Lead To Alzheimer's 2
J Cortex Extrator - Angled Right
J Cannula
J Hydrodissector - Newman
Side Cutting Cystotome
Medicine Products: